芳酶抑制剂治疗单独或与GH一起增加了矮身青春期男孩的最终身高 - 现实世界数据
Michal Yackobovitch-Gavan1,2, Ariel Tenenbaum1,3, Moshe Phillip1,3
1The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
短身男孩的芳香酶抑制剂 (AI) 治疗延长了他们的生长期,导致成年人身高 (AHt) 超过预测. 这种方法对骨年龄较高或异常矮身 (ISS) 的男孩有希望.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 增长激素治疗疗法 增长激素治疗
- 青春期发展 青春期发展
背景情况:
- 在青春期中期的男孩中,身材矮小会带来治疗上的挑战.
- 芳酶抑制剂 (AI) 可能会延迟体融合并增强成人身高 (AHt).
研究的目的:
- 评估人工智能治疗在青春期中期的男孩中对AHt的疗效,这些男孩预测的成人身高较低 (PAHt).
- 为了评估AI治疗的男孩与先进的骨年龄 (BA) 或特异性矮身 (ISS).
主要方法:
- 在儿科内分泌推中心进行了回顾性研究.
- 将人工智能治疗的男孩 (快速青春期或GH的ISS) 与匹配的对照进行了比较.
- 追踪人类学,BA,PAHt,并实现了AHt.
主要成果:
- 人工智能治疗改善了PAHt,并降低了骨龄-SD得分 (BASDS).
- 与对照组相比,接受人工智能治疗的组获得了更高的AHt.
- 获得的AHt和基线PAHt之间的差异在接受AI治疗的组中更为明显.
结论:
- 人工智能治疗有效地延长了矮身男孩的生长期.
- 通过人工智能疗法实现的AHt超出了最初的预测.
- 人工智能显示出男孩具有高级BA或ISS的潜力,有或没有GH治疗.
更多相关视频
06:38Determination of Reproductive Competence by Confirming Pubertal Onset and Performing a Fertility Assay in Mice and Rats
Published on: October 13, 2018
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
相关概念视频
Nature and Nurture
Signs of Puberty
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Polygenic Traits
